Magpale, Michelle .
HRN: 25-79-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2024
CEFUROXIME 500MG (TAB)
09/13/2024
09/19/2024
PO
1 Tab
Bid
Prom X 12hrs
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes